The HCPLive influenza page is a resource for medical news and expert insights on the flu. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for influenza, and more.
May 16th 2024
An analysis of FDA Adverse Event Reporting System data suggests baloxavir marboxil has lower hepatic toxicity than oseltamivir and may be a safer option for patients with liver diseases.
COVID-19 Restrictions Result in Drop of Other Respiratory Viruses
There was a positive rate of 9.88 positive results per 100 tests during a 4 month period in 2020, significantly lower than the positivity rate of 29.90 positive results per 100 tests observed for the same date range during the previous 5 virus years.